the cells were exposed to UHMWPE particles. Decoy ODN treatment enhanced the ALP activity to 34.08±9.24IU/L in UHMWPE particle-exposed cultures. Runx2 and osteopontin RNA expression at day 14 was reduced by either decoy ODN alone or particle exposure. Osteopontin but not Runx2 expression was increased by decoy ODN in the presence of particles. Bone mineralization (Alizarin red stain) of MSCs at day 21 was reduced 58.7±2.0% by particle exposure, and decoy ODN reversed the reduction. Decoy ODN also increased bone mineralization in MSCs with no particles by 32.6±5.5%. Similar phenotypes of cell viability and osteogenic differentiation in the presence of particles and decoy ODN were also confirmed using human MSCs. Discussion: Our results suggest that suppression of NF-κB activity by decoy ODN may protect MSCs from the adverse effects of wear particle exposure via 3 distinct pathways including 1) suppressing the immune response by induction of TGF-β1 expression, 2) enhancing osteogenesis signaling and cell viability, and 3) suppressing osteoclastogenesis by enhancing osteoprotegerin expression. The strategic use of NF-κB ODN could potentially mitigate wear particle-induced peri-prosthetic osteolysis. Significance: Modulation of wear particle induced inflammation by NF-κB decoy ODN had no adverse effects on MSCs, and may potentially further mitigate peri-prosthetic osteolysis by protecting MSC viability and osteogenic ability.
